Skip to main content
Livermore
Livermore
ZHEN

Jackson Square Partners, LLC

SEC CIK
0001605911
Latest filing
Feb 13, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by Jackson Square Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q4 2025 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of PACB by Jackson Square Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−553,103−100.0%Sold outHolders
Q2 2025553,103$685.8K0.3%−2,767,258−83.3%ReducedHolders
Q1 20253,320,361$3.92M0.5%−1,788,905−35.0%ReducedHolders
Q4 20245,109,266$9.35M1.0%−1,186,850−18.9%ReducedHolders
Q3 20246,296,116$10.7M0.9%−2,587,327−29.1%ReducedHolders
Q2 20248,883,443$12.2M0.7%+1,699,130+23.7%AddedHolders
Q1 20247,184,313$26.9M1.1%−2,520,453−26.0%ReducedHolders
Q4 20239,704,766$95.2M3.1%+2,770,901+40.0%AddedHolders
Q3 20236,933,865$57.9M1.9%−1,583,759−18.6%ReducedHolders
Q2 20238,517,624$113.3M3.3%−3,580,337−29.6%ReducedHolders
Q1 202312,097,961$140.1M3.8%−2,907,216−19.4%ReducedHolders
Q4 202215,005,177$122.7M3.3%−5,252,922−25.9%ReducedHolders
Q3 202220,258,099$117.6M3.1%−2,503,943−11.0%ReducedHolders
Q2 202222,762,042$100.6M2.3%+219,453+1.0%AddedHolders
Q1 202222,542,589$205.1M2.0%+8,039,420+55.4%AddedHolders
Q4 202114,503,169$296.7M2.5%−33,502−0.2%ReducedHolders
Q3 202114,536,671$371.4M2.4%−299,823−2.0%ReducedHolders
Q2 202114,836,494$518.8M3.0%+1,924,799+14.9%AddedHolders
Q1 202112,911,695$430.1M2.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.